2018
DOI: 10.1007/s42399-018-0029-0
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Baseline Cholinesterase in Patients with Primary Liver Tumors Undergoing Radioembolization: Impact on Outcome

Abstract: The purpose of our study was to determine cutoff values for baseline cholinesterase (CHE) and bilirubin levels prognostic for outcome after radioembolization (RE) in patients with primary liver tumors. In this retrospective single-center study, a threshold for baseline levels of CHE and bilirubin was determined based on overall survival (OS) of patients with refractory primary liver tumors who underwent RE. Between-group differences based on the dichotomized cohort were assessed with the log-rank test. We anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…After implementing our exclusion criteria, 47 papers were eligible for data extraction. Of the final 47 included papers, 40 were journal articles [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 ] ( Table 1 ), and seven were conference abstracts [ 62 , 63 , 64 , 65 , 66 , 67 , 68 ] ( Table 2 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…After implementing our exclusion criteria, 47 papers were eligible for data extraction. Of the final 47 included papers, 40 were journal articles [ 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 ] ( Table 1 ), and seven were conference abstracts [ 62 , 63 , 64 , 65 , 66 , 67 , 68 ] ( Table 2 ).…”
Section: Resultsmentioning
confidence: 99%
“…Thirty studies included both treatment-naïve patients and those with the recurrent disease following other treatments, five studies assessed only outcomes following SIRT as a first-line therapy [ 29 , 42 , 43 , 44 , 54 ] and nine studies included only patients in whom prior treatments had failed [ 22 , 24 , 27 , 34 , 38 , 47 , 55 , 56 , 66 ]. The remaining three studies did not provide details on their patient populations [ 62 , 64 , 68 ].…”
Section: Resultsmentioning
confidence: 99%